Senseonics CMO receives RSU and option awards
Senseonics Holdings, Inc. reported that Chief Medical Officer Francine Kaufman received equity-based compensation on May 19, 2026.
Rhea-AI Filing Summary
Senseonics Holdings, Inc. reported that Chief Medical Officer Francine Kaufman received equity-based compensation on May 19, 2026. She was granted 63,177 restricted stock units, each representing a contingent right to one share of common stock. Following this grant, she holds 181,067 common shares directly.
She was also awarded an employee stock option for 86,935 shares of common stock at an exercise price of $5.54 per share, expiring on May 18, 2036. The RSUs vest in eight equal installments beginning June 15, 2026, while the options vest in 48 equal monthly installments starting May 19, 2026, in each case subject to her continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 150,112 shares
Grant/Award
2 txns
Insider
Kaufman Francine
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 86,935 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 63,177 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 86,935 contracts (Direct);
Common Stock — 181,067 shares (Direct)
Footnotes (3)
- F1. Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026 and the remaining seven installments vesting in six month increments commencing on November 15, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3. The options vest in 48 equal monthly installments commencing on May 19, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Key Figures
RSU grant size: 63,177 units
Shares held after RSU grant: 181,067 shares
Option grant size: 86,935 options
+4 more
7 metrics
RSU grant size
63,177 units
Each RSU equals one share of common stock
Shares held after RSU grant
181,067 shares
Common stock directly owned after non-derivative transaction
Option grant size
86,935 options
Employee stock option for common stock
Option exercise price
$5.54 per share
Conversion or exercise price of employee stock option
Option expiration
May 18, 2036
Expiration date of employee stock option grant
RSU vesting start
June 15, 2026
First of eight equal RSU vesting installments
Option vesting start
May 19, 2026
First of 48 equal monthly option vesting installments
Key Terms
restricted stock unit ("RSU"), Employee Stock Option (right to buy), vesting, contingent right
4 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") grant."
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) with underlying common stock."
vesting financial
"The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
FAQ
What insider transactions did SENS Chief Medical Officer Francine Kaufman report?
Francine Kaufman reported equity awards, not open-market trades. She received 63,177 restricted stock units and an option for 86,935 shares, both as compensation awards that vest over time, subject to her continued service with Senseonics Holdings.
What are the key terms of Francine Kaufman’s RSU grant at Senseonics (SENS)?
Kaufman’s RSU grant covers 63,177 units, each equal to one share of common stock. The RSUs vest in eight equal instalments starting June 15, 2026, then every six months through November 15, 2029, provided she remains in continuous service with the company.
What are the terms of the employee stock option granted to Francine Kaufman by SENS?
She received an employee stock option for 86,935 shares of Senseonics common stock with a $5.54 exercise price. The option vests in 48 equal monthly installments beginning May 19, 2026 and expires on May 18, 2036, assuming continued service through each vesting date.
Is Francine Kaufman’s Form 4 for SENS a stock purchase or sale?
The Form 4 reflects equity awards, not market purchases or sales. Both reported transactions use code “A,” indicating grants or awards of RSUs and stock options as compensation. No open-market buy or sell transactions were reported in this filing.
How do the RSU and option vesting schedules work for SENS Chief Medical Officer?
The RSUs vest in eight equal tranches from June 15, 2026, then every six months. The options vest monthly over 48 months starting May 19, 2026. In both cases, vesting requires Francine Kaufman to remain in continuous service with Senseonics Holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
